Company Description
Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States.
The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.
It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services.
In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services.
The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Country | United States |
Founded | 2008 |
IPO Date | Oct 25, 2019 |
Industry | Healthcare Plans |
Sector | Healthcare |
Employees | 680 |
CEO | Peter Anevski |
Contact Details
Address: 1359 Broadway New York, New York 10018 United States | |
Phone | 212 888 3124 |
Website | progyny.com |
Stock Details
Ticker Symbol | PGNY |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $13.00 |
CIK Code | 0001551306 |
CUSIP Number | 74340E103 |
ISIN Number | US74340E1038 |
Employer ID | 27-2220139 |
SIC Code | 8090 |
Key Executives
Name | Position |
---|---|
Peter Anevski CPA | Chief Executive Officer and Director |
David J. Schlanger J.D. | Executive Chairman |
Michael Sturmer | President |
Mark S. Livingston CPA | Chief Financial Officer |
Allison Swartz | Executive Vice President, General Counsel and Secretary |
Steven Leist | Chief Technology Officer |
James Hart | Vice President of Investor Relations |
Risa Fisher | Chief Marketing Officer |
Cassandra Pratt | Chief Human Resources Officer |
Julie Stadlbauer | Chief Business Development Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 3, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
Mar 3, 2025 | 10-K | Annual Report |
Feb 28, 2025 | 8-K/A | [Amend] Current report |
Feb 27, 2025 | 8-K | Current Report |
Jan 16, 2025 | 8-K | Current Report |
Jan 13, 2025 | 8-K | Current Report |
Dec 9, 2024 | 144 | Filing |
Dec 6, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 12, 2024 | 10-Q | Quarterly Report |